# Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil

> **NCT05959720** · — · RECRUITING · sponsor: **Instituto do Cancer do Estado de São Paulo** · enrollment: 180 (estimated)

## Conditions studied

- Acute Lymphoid Leukemia
- Minimal Residual Disease
- Gene Abnormality
- Chemotherapeutic Toxicity

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Vincristin
- **DRUG:** Daunorubicin
- **DRUG:** Peg-asparaginase
- **DRUG:** Intrathecal Suspension
- **DRUG:** Cyclophosphamide
- **DRUG:** Cytarabine
- **DRUG:** Mercaptopurine
- **DRUG:** Methotrexate
- **DRUG:** Doxorubicin

## Key facts

- **NCT ID:** NCT05959720
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-05
- **Primary completion:** 2028-06
- **Final completion:** 2030-06
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05959720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05959720, "Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05959720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*